Welcome to the Lattice Brief, 3DHEALS weekly newsletter. This week, Elevation Spine received 510(k) clearance for Saber-C AVIA, a zero-profile cervical fusion device built on a porous 3D-printed titanium interbody (July 29, 2026). A year ago, that would have been a headline. Now it is just another Tuesday. Lincotek’s SpineLinc (Jan 2026) and Spinal Elements’ Ventana A (March 2026) have all been cleared recently. Additive titanium has quietly become a default production route for spine implants, not an experiment.
Why does it matter clinically?
The porous lattice isn’t decoration. According to a recently published review article, “3D-Printed Porous Titanium Cages in Lumbar Interbody Fusion,” 3D-printed porous titanium cages let engineers tune pore size and porosity so the cage’s stiffness approaches cancellous bone, reducing the stress-shielding stiff solid implants cause, while the roughened, interconnected surface supports bone ingrowth. Preclinical work shows higher bone-implant contact and bone-volume fraction than solid titanium or PEEK implants. Additionally, early clinical series also reported high radiographic fusion and maintained disc height, although the authors admit that the sample sizes were small and follow-up was short (review).
Why does it matter commercially?
This is one of additive manufacturing’s least glamorous, most durable beachheads in medicine. Spine is a large, reimbursed market with a clear predicate pathway, so 510(k)s clear steadily, and OEMs compete on time-to-market. Titanium is still the workhorse. A 2025 meta-analysis found porous titanium and the pricier porous tantalum biologically equivalent, so titanium wins on weight and cost (meta-analysis).
While the majority of cervical interbody cages are still traditionally manufactured, the cadence of new FDA-cleared 3D-printed implants signals market appetite. We should keep an eye out for post-market clinical trial data, especially patient-reported outcome metrics. Latest studies show favorable outcomes, but only time will tell whether using a 3D-printed cervical fusion device is an incremental improvement or a monumental change (review).
Regulatory watch
- Elevation Spine – Saber-C AVIA 510(k) clearance — porous 3D-printed titanium cervical interbody, cleared Jul 29 (the week’s lead – see The big thing). No other new 510(k)s surfaced this week; DARPA and ARPA-H: no new 3DP activity.
Clinical & research
- Microvasculature via bioprinting (review) (npj Biomedical Innovations) — maps the perfusion bottleneck and scaffold-free routes around it (via PubMed)
- High-filler zirconia 3D-printed dental resins (J Prosthodont Res) — printed resins now rival CAD-CAM ceramic blocks on strength (via PubMed)
- Bioactive 3D-printed heart-valve scaffold (Bioactive Materials) — engineered for endothelialization and reduced early inflammation (via PubMed)
Also this week
- 3D Printing News Briefs, July 30 – Orthodontics, Digital Implants & More (3DPrint.com) — in-house digital dental implants, an orthodontics update, and a new wax printer
- Precision micromolding advances for next-generation implantable devices (MD+DI) — the adjacent manufacturing story behind the AM-implant boom
- After 17 years at 3D Systems, Katie Weimer bets on regenerative breast tissue (3DPrint.com) — a bioprinting commercialization signal
From 3DHEALS
- The Lattice, Ep. 121 – Absorbable Biomaterials with Dr. Rao Bezwada — new this week (Jul 30): how absorbable biomaterials power implants, sutures, and drug-delivery systems that safely degrade
- Upcoming event – New Approach Methodologies: From Theory to Validation (Aug 20) — NAMs shifting preclinical safety from animal models to human-relevant, technology-driven approaches
Comments